Hikers Beware: Acute Mountain Sickness Can Be Fatal

Main Category: Sports Medicine / Fitness
Article Date: 05 Jul 2007 - 12:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Acute mountain sickness (AMS) affects almost half of those ascending to heights over 3,000m and may lead to life-threatening complications such as pulmonary or cerebral edema. A new study appearing in the Journal of Travel Medicine details a prospective on-site study in the Himalayas between July and October 2004 in which the knowledge and practices concerning AMS were examined amongst trekkers.

The interest of the general public in AMS is thought to have increased over the past 25 years. This change is partly due to media exposure, trekking guidebooks and the wide availability of the Internet. In spite of these apparent changes, it is unknown whether there is an actual increased awareness among those who actually climb to these altitudes, and if this awareness is accompanied by a decrease in the prevalence of AMS. The study aimed to characterize the knowledge among high-altitude trekkers regarding symptoms, prevention, and treatment of AMS, and to examine whether this knowledge is translated into practice.

92 percent had heard of AMS prior to their current trip. Overall, awareness of AMS among trekkers was good, particularly in regard to symptoms and modes of treatment. Almost 90 percent of the travelers were found to have "basic knowledge" of AMS and could recognize its symptoms (such as headache, plus 2 or more of the following: fatigue, dizziness, nausea, insomnia). 72 percent knew that descent was the primary mode of treatment. However, a fundamental mode of treatment, oxygen, was known to less than 10 percent of travelers.

47 percent of those surveyed suffered from AMS and nearly 25 percent of the participants did not know that AMS could be prevented. Additionally, 15 percent of those surveyed believed AMS to start above 4,000m, placing them at risk at altitudes between 3,000m and 4,000m.

Implementation is lacking for translating seemingly adequate knowledge of AMS into practical action. The findings indicate that there is room for improvement, and they offer a major challenge to travel health care providers. Pre-travel consultation regarding AMS should be given by professionals with special attention to practical advice.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

This study is published in the Journal of Travel Medicine.

The Journal of Travel Medicine publishes up-to-date research and original, peer-reviewed articles in the challenging field of travel medicine, including: prevention and treatment of disease; clinic management; patient and staff education; immunizations; impact of travel on host countries; military medicine; problems of refugees; diseases such as malaria, travelers' diarrhea, hepatitis, TB, STDs and AIDS, jet lag, altitude sickness, trauma, special hosts, and more. For more information, please visit: http://www.blackwell-synergy.com/loi/jtm

Wiley-Blackwell was formed in February 2007 as a result of the merger between Blackwell Publishing Ltd. and John Wiley & Sons, Inc.'s Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,250 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit http://www.blackwellpublishing.com/ or http://interscience.wiley.com/.

Contact: Sean Wagner
Blackwell Publishing Ltd.